[go: up one dir, main page]

NO20073850L - Farmasoytisk polymersammensetning for oral kontrollert frigivelsesavlevering av terbutalinsulfat - Google Patents

Farmasoytisk polymersammensetning for oral kontrollert frigivelsesavlevering av terbutalinsulfat

Info

Publication number
NO20073850L
NO20073850L NO20073850A NO20073850A NO20073850L NO 20073850 L NO20073850 L NO 20073850L NO 20073850 A NO20073850 A NO 20073850A NO 20073850 A NO20073850 A NO 20073850A NO 20073850 L NO20073850 L NO 20073850L
Authority
NO
Norway
Prior art keywords
terbutaline sulfate
controlled release
polymeric composition
release delivery
derivative
Prior art date
Application number
NO20073850A
Other languages
English (en)
Inventor
Adnan Badwan
Mayyas Al-Remawi
Original Assignee
Jordanian Pharmaceutical Mfg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jordanian Pharmaceutical Mfg filed Critical Jordanian Pharmaceutical Mfg
Publication of NO20073850L publication Critical patent/NO20073850L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Farmasøytisk regulertfrigivningspreparat som gir en vedvarende avlevering av det basiske legemidlet terbutalinsulfat, hvor preparatet innbefatter i det minste terbutalinsulfat eller et derivat derav som et aktivt middel, og videre innbefatter en inaktiv matriks, hvor nevnte matriks innbefatter en hydrofil polysakkarid polymerblanding, hvilken blanding innbefatter kitosan eller et derivat derav, og ytterligere innbefatter xantangummi eller et derivat derav, hvor forholdet for xantangummi og kitosan inne i nevnte blanding er i området fra ca. 1:10 til ca. 10:1, og hvor preparatet eventuelt innbefatter natrium bikarbonat.
NO20073850A 2005-01-19 2007-07-23 Farmasoytisk polymersammensetning for oral kontrollert frigivelsesavlevering av terbutalinsulfat NO20073850L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05000985A EP1685831B1 (en) 2005-01-19 2005-01-19 Pharmaceutical polymer composition for oral controlled release delivery of terbutaline sulfate
PCT/EP2005/013530 WO2006076951A1 (en) 2005-01-19 2005-12-29 Pharmaceutical polymer composition for oral controlled-release delivery of terbutaline sulfate

Publications (1)

Publication Number Publication Date
NO20073850L true NO20073850L (no) 2007-10-10

Family

ID=34933362

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20073850A NO20073850L (no) 2005-01-19 2007-07-23 Farmasoytisk polymersammensetning for oral kontrollert frigivelsesavlevering av terbutalinsulfat

Country Status (13)

Country Link
US (1) US20080206334A1 (no)
EP (2) EP1685831B1 (no)
KR (1) KR20070100364A (no)
CN (1) CN101102756A (no)
AT (1) ATE355833T1 (no)
BR (1) BRPI0519622A2 (no)
CA (1) CA2592269A1 (no)
DE (1) DE602005000675T2 (no)
EA (1) EA013969B1 (no)
ES (1) ES2284088T3 (no)
NO (1) NO20073850L (no)
WO (1) WO2006076951A1 (no)
ZA (1) ZA200705660B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011031620A1 (en) * 2009-09-11 2011-03-17 Transtech Pharma, Inc. Solid compositions comprising an oxadiazoanthracene compound and methods of making and using the same
CN102188399B (zh) * 2011-04-02 2012-12-12 南京正科制药有限公司 托拉塞米胃漂浮片及其制备方法
CN110057932B (zh) * 2019-04-22 2022-03-15 上海旭东海普药业有限公司 高效液相色谱分析硫酸特布他林有关物质的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0187703B1 (en) * 1985-01-11 1992-08-05 Teijin Limited Sustained release preparation
US5620706A (en) * 1995-04-10 1997-04-15 Universite De Sherbrooke Polyionic insoluble hydrogels comprising xanthan and chitosan

Also Published As

Publication number Publication date
KR20070100364A (ko) 2007-10-10
EP1838299A1 (en) 2007-10-03
CA2592269A1 (en) 2006-07-27
CN101102756A (zh) 2008-01-09
EA013969B1 (ru) 2010-08-30
EA200701525A1 (ru) 2008-02-28
WO2006076951A1 (en) 2006-07-27
ES2284088T3 (es) 2007-11-01
US20080206334A1 (en) 2008-08-28
ATE355833T1 (de) 2007-03-15
DE602005000675T2 (de) 2007-11-15
ZA200705660B (en) 2009-01-28
EP1685831B1 (en) 2007-03-07
DE602005000675D1 (de) 2007-04-19
EP1685831A1 (en) 2006-08-02
BRPI0519622A2 (pt) 2009-02-25

Similar Documents

Publication Publication Date Title
EA200700049A1 (ru) Препаративные формы оральных лекарственных форм мемантина с модифицированным высвобождением
WO2007048219A3 (en) Sustained drug release composition
PE20061449A1 (es) Composiciones farmaceuticas comprendiendo imatinib y un retardador de liberacion
TW200716202A (en) Pediatric formulation of topiramate
UY32503A (es) Formulación pesticida de uso agrícola a base de avermectina y un agente fotoprotector
NO20062082L (no) Pellets inneholdende venlafaksinhydroklorid
RS52777B (en) CURRENT RELEASE THERAPY SYSTEM FOR IMPROVED ORAL ABSORPTION 7 - [(E) -TERT-BUTYLOXYIMINOMETHYL] CAMPTOTECIN
MY139086A (en) Use of debranched starch in extrusion-spheronization pharmaceutical pellets
MX2011005633A (es) Formas de dosificacion solida de bendamustina.
NO20082047L (no) Sakte frigivende sammensetning, fremgangsmate for fremstilling derav og anvendelse av samme
CY1107819T1 (el) Φαρμακευτικη διαμορφωση της ολανζαπινης
NO20074933L (no) Farmasoytisk sammensetning som innbefatter et indolylmaleimidderivat
NO20073850L (no) Farmasoytisk polymersammensetning for oral kontrollert frigivelsesavlevering av terbutalinsulfat
BRPI0611526A2 (pt) composição tópica contendo gelatina
EA201070806A1 (ru) Состав медленного высвобождения на основе ассоциации гликогена и альгината
MX2008010879A (es) Composiciones farmaceuticas de sodio de fluvastatina.
RS51578B (en) SOLID PHARMACEUTICAL COMPOSITION CONTAINING TELITROMYCIN
DE60319983D1 (de) Universelle Zusammensetzung zur kontrollierten Wirkstoffabgabe enthaltend Chitosan
DE60219965D1 (de) Lang wirkende zusammensetzungen enthaltend zidovudine und/oder lamivudine
WO2009008004A3 (en) Sustained release formulations of divalproex sodium
UA94275C2 (ru) Фармацевтическая композиция, которая содержит по крайней мере один активный наркотический или психотропный компонент, назначенный способ введения которых в организм тяжело поддается изменению
JO2440B1 (en) Formulation of oral pharmaceutical polymers for controlled release of terbutalate sulfate.
JO2571B1 (en) A general composition of controlled liberation
JO2572B1 (en) A general formula for controlled release
BRPI0602051A (pt) composição farmacêutica

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application